|
Symbol
|
KAJDEU | RMBE7V | ABVHSQ | PBURCH | RMA3QV | Z0ARNZ | Z0ATQZ | LZJRCH | LZQRCH | QXPRCH | RMAKZV | QZKRCH | AEFRTQ | RMA0TV | ADIESQ | RMBXZV | ROMRCH | AFNHTQ | RMB4JV | RMADEV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | GOAL | Multi Vonti | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti |
|
Sous-jacent
|
Julius Baer Group / Sandoz Group AG / Sika AG | Alcon / Sandoz Group AG | Sika AG / Helvetia Baloise Holding AG / Straumann Hldg. AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG | Givaudan / Novartis AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | DKSH Hldg. AG / Sandoz Group AG / Siegfried Hldg. AG | Alcon / Sandoz Group AG / UBS Group AG | Galderma Group AG / Lonza Group N / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Givaudan / Novartis AG / Sandoz Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG | ABB / Sandoz Group AG / Swisscom N |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
06.07.2026 | 13.07.2026 | 07.10.2026 | 21.07.2026 | 09.11.2026 | 25.08.2026 | 07.09.2026 | 24.07.2026 | 07.08.2029 | 25.08.2027 | 01.09.2028 | 08.06.2027 | 24.09.2027 | 19.11.2026 | 24.11.2027 | 20.12.2027 | 23.07.2027 | 09.02.2029 | 14.02.2028 | 01.12.2026 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
171,68 | 64,50 | 183,04 | 57,988 | 56,14 | 463,386 | 12,496 | 67,425 | 2 627,25 | 52,905 | 65,00 | 425,25 | 383,04 | 57,20 | 50,768 | 205,90 | 419,40 | 80,752 | 677,60 | 643,30 |
| rendement max. p.a. | 214,78% | 602,46% | - | - | 21,74% | 0,56% | 10,20% | 16,58% | 4,77% | 10,07% | 7,24% | 5,18% | 6,75% | 4,40% | 10,02% | 4,85% | 5,68% | 4,19% | 12,94% | 19,94% |
| Demande | - | 85,70 | 93,14 | 95,29 | 94,30 | - | - | 98,62 | 99,02 | 94,69 | 94,10 | 99,64 | 99,21 | 99,40 | 98,29 | 99,50 | 100,68 | 100,63 | 91,30 | 96,80 |
| Offre | - | 87,00 | - | - | 95,30 | - | - | 99,42 | 99,82 | 95,49 | 95,30 | 100,44 | 100,01 | 100,60 | 99,09 | 100,50 | 101,49 | 101,44 | 92,30 | 97,80 |